Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.

Revenue
+13.7%
EPS
+42.0%
Free cash flow
+120.9%
Total debt
−1.59%

Quarter to July 2026, against a year earlier

102.14 2.70 −2.58%
Market cap
$134.1B
P/E
25.6×
Fwd P/E
20.8×
Dividend yield
2.74%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Medtronic PLC (MDT) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 1.5× (July 2015) to 3.9× (January 2015); the current reading is higher than 76% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 2.1× (8.21%)
FY2025 2.3× 6.87%
FY2024 2.1× (9.47%)
FY2023 2.3× (11.12%)
FY2022 2.6× (23.04%)
FY2021 3.4× 32.62%
FY2020 2.6× 8.05%
FY2019 2.4× 11.33%
FY2018 2.1× (6.76%)
FY2017 2.3× 6.79%

Quarterly newest first

Period P/B ratio Change
Jul 2026 2.1× 3.68%
Apr 2026 2.1× (22.59%)
Jan 2026 2.7× 12.51%
Oct 2025 2.4× (0.95%)
43 more quarters

Against its own ten years

Low 1.5× High 3.9×
Ten-year median 2.3×
Current reading's percentile 76

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on MDT